Gerrit Nijveldt is currently Senior Director Global Regulatory Affairs Labeling for the therapeutic area Diabetes and Devices for Sanofi in Bridgewater NJ. Gerrit has more than 18 years of experience in Global labeling. He has a broad experience in developing and maintaining Company Core Data Sheets, US Prescribing Information and EU Summary of Product Characterisation, including the labeling for multiple development products (early phase to approval). Gerrit has experience with information management tools, SPL, agency inspections and setting up end-to-end labeling process. Gerrit is also an associate adjunct professor for Temple University School of Pharmacy teaching Global Labeling in the Quality Assurance and Regulatory Affairs Master’s Program and is part of the DIA Labeling Steering Committee. Gerrit earned his MSc in Medical Biology from University of Utrecht in the Netherlands and started working in pharmaceutical industry in 1991, in the Netherlands, in Regulatory Affairs and Medical Information department.